EP 2040705 A2 20090401 - USE OF 2-BENZOYL-IMIDAZOPYRIDINES IN THERAPEUTICS
Title (en)
USE OF 2-BENZOYL-IMIDAZOPYRIDINES IN THERAPEUTICS
Title (de)
VERWENDUNG VON 2-BENZOYL-IMIDAZOPYRIDINENE IN THERAPEUTIKA
Title (fr)
UTILISATION DE 2-BENZOYL-IMIDAZOPYRIDINES EN THÉRAPEUTIQUE
Publication
Application
Priority
- FR 2007001124 W 20070703
- FR 0606011 A 20060703
Abstract (en)
[origin: WO2008003855A2] The invention relates to the therapeutic use of derivatives having general formula (I) in which: X is a phenyl, R<SUB>1,</SUB> R<SUB>2</SUB>, R<SUB>3 </SUB>and R<SUB>4</SUB> are hydrogens; or X is a phenyl, R<SUB>3</SUB> is methyl and R<SUB>1</SUB>, R<SUB>2</SUB>and R<SUB>4</SUB> are hydrogens; or X is a phenyl, R<SUB>2</SUB> is chlorine or methoxy and R<SUB>1</SUB>, R<SUB>3</SUB> and R<SUB>4</SUB> are hydrogens; or X is a phenyl, R<SUB>2</SUB> and R<SUB>3</SUB> are methoxy and R<SUB>1</SUB> and R<SUB>4</SUB> are hydrogens; or X is a phenyl, R<SUB>1 </SUB>is methoxy and R<SUB>2</SUB>, R<SUB>3</SUB> and R<SUB>4</SUB> are hydrogens; or X is a phenyl, R<SUB>3</SUB> is methoxy and R<SUB>1</SUB>, R<SUB>2</SUB> and R<SUB>4 </SUB>are hydrogens; or X is a 4-methylphenyl, R<SUB>2</SUB>is a methyl and<SUB/>R<SUB>1</SUB>, R<SUB>3</SUB> and R<SUB>4 </SUB>are hydrogens; or X is a 4-chlorophenyl, R<SUB>1</SUB> is a chlorine or a methoxy or a methyl, and R<SUB>2</SUB>, R<SUB>3</SUB> and R<SUB>4</SUB> are hydrogens; or X is a 4-chlorophenyl, R<SUB>2</SUB> is a chlorine or a methyl and R<SUB>1</SUB>, R<SUB>3</SUB> and R<SUB>4 </SUB>are hydrogens; or X is a 4-chlorophenyl, R<SUB>3</SUB> is a methyl and R<SUB>1</SUB>, R<SUB>2</SUB> and R<SUB>3 </SUB>are hydrogens; or X is 4-chlorophenyl, R<SUB>4</SUB> is a methyl and R<SUB>1</SUB>, R<SUB>2 </SUB>and<SUB/>R<SUB>4 </SUB>are hydrogens; or X is a 4-chlorophenyl, R<SUB>1</SUB> and R<SUB>3 </SUB>are methyls and<SUB/>R<SUB>2 </SUB>and R<SUB>4</SUB> are hydrogens, or X is a 4-chlorophenyl and R<SUB>1</SUB>, R<SUB>2,</SUB> R<SUB>3</SUB> and R<SUB>4 </SUB>are hydrogens, or X is a 2-chlorophenyl and R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>3</SUB>and R<SUB>4</SUB> are hydrogens, or X is a 4-methylphenyl and R<SUB>1</SUB>, R<SUB>2</SUB>, R<SUB>3</SUB>and R4 are hydrogens, said derivatives taking the form of a base or an acid addition salt.
IPC 8 full level
A61K 31/437 (2006.01); A61P 19/10 (2006.01); A61P 25/00 (2006.01); A61P 25/08 (2006.01); A61P 25/16 (2006.01); A61P 25/18 (2006.01); A61P 25/24 (2006.01); A61P 25/28 (2006.01); A61P 25/30 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP KR US)
A61K 31/437 (2013.01 - EP KR US); A61P 19/10 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/08 (2017.12 - EP); A61P 25/16 (2017.12 - EP); A61P 25/18 (2017.12 - EP); A61P 25/24 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 25/30 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
See references of WO 2008003855A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA HR MK RS
DOCDB simple family (publication)
FR 2903106 A1 20080104; FR 2903106 B1 20100730; AU 2007271083 A1 20080110; BR PI0714318 A2 20140624; CA 2655552 A1 20080110; CN 101484164 A 20090715; EP 2040705 A2 20090401; IL 195817 A0 20090901; JP 2009541470 A 20091126; KR 20090033863 A 20090406; MX 2008016560 A 20090119; RU 2009103321 A 20100810; US 2009143421 A1 20090604; WO 2008003855 A2 20080110; WO 2008003855 A3 20080306
DOCDB simple family (application)
FR 0606011 A 20060703; AU 2007271083 A 20070703; BR PI0714318 A 20070703; CA 2655552 A 20070703; CN 200780025168 A 20070703; EP 07803832 A 20070703; FR 2007001124 W 20070703; IL 19581708 A 20081209; JP 2009517331 A 20070703; KR 20097000040 A 20090102; MX 2008016560 A 20070703; RU 2009103321 A 20070703